Department of Surgery, Ryhov County Hospital, SE-551 85, Jönköping, Sweden.
Br J Surg. 2016 May;103(6):676-683. doi: 10.1002/bjs.10086. Epub 2016 Mar 2.
Calcium supplementation has been proposed after bilateral thyroid surgery, either to all patients or to those with biochemical hypocalcaemia. It has also been suggested that supplementation aids parathyroid recovery and prevents permanent hypoparathyroidism. This single-centre study investigated the feasibility of a restrictive management of post-thyroidectomy hypocalcaemia.
Serum calcium was checked before surgery, on postoperative day 1 (POD) 1, at a follow-up visit 6-8 weeks after surgery and after a minimum of 12 months in all patients. Regardless of serum calcium levels, patients with symptoms of hypocalcaemia were prescribed oral calcium supplementation (0·5-1·0 g twice daily) and asymptomatic patients were not. Asymptomatic patients were informed about hypocalcaemic symptoms and instructed to contact the surgical ward should symptoms appear.
Some 640 patients underwent bilateral thyroid surgery without previous or intentional simultaneous parathyroidectomy. A subnormal serum calcium level (below 2·15 mmol/l) was observed in 412 patients (64·4 per cent) on POD 1. By comparison, only 63 patients (9·8 per cent) experienced symptoms of hypocalcaemia in the postoperative period, all but one with a corresponding biochemical hypocalcaemia on POD 1. Calcium levels in all patients with asymptomatic postoperative hypocalcaemia recovered to normal without supplementation. Serum calcium was also normalized during follow-up in all symptomatic patients, except 22 (3·4 per cent) who became permanently hypoparathyroid. No patient without early hypocalcaemic symptoms developed permanent hypoparathyroidism.
The proposed restrictive management of postoperative hypocalcaemia after bilateral thyroid surgery avoids unnecessary supplementation for most patients.
甲状腺手术后建议补钙,要么对所有患者,要么对生化低钙血症患者。还有人认为补充钙有助于甲状旁腺恢复并预防永久性甲状旁腺功能减退症。本单中心研究旨在调查甲状腺切除术后低钙血症限制性管理的可行性。
所有患者术前、术后第 1 天(POD1)、术后 6-8 周随访及术后至少 12 个月时检查血清钙。无论血清钙水平如何,有低钙血症症状的患者均给予口服钙剂(0.5-1.0 g,每日 2 次),无症状患者则不补充。无症状患者被告知低钙血症的症状,并告知如有症状应联系外科病房。
640 例患者行双侧甲状腺切除术,术前无甲状旁腺切除术或非故意同时行甲状旁腺切除术。412 例(64.4%)患者术后第 1 天血清钙水平降低(低于 2.15mmol/L)。相比之下,仅 63 例(9.8%)患者在术后出现低钙血症症状,其中无一例在 POD1 时伴有相应的生化低钙血症。所有无症状术后低钙血症患者的血钙水平在未补充的情况下恢复正常。所有有症状的患者的血钙水平在随访期间也恢复正常,除 22 例(3.4%)患者永久性甲状旁腺功能减退。没有早期无症状低钙血症的患者发生永久性甲状旁腺功能减退症。
本研究提出的双侧甲状腺手术后低钙血症的限制性管理方法避免了大多数患者不必要的补钙。